跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
allergy vaccine
首页
药物
allergy vaccine
allergy vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SELF-ASSEMBLING NANOPARTICLES
EP 4608455 A1
申请人: BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC
优先权: 2022
CN
EP
US
WO
7 件公开
PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN
US 2015118264 A1
申请人: CUREVAC GMBH
优先权: 2012
CN
EP
US
5 件公开
Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy
US 8491910 B2
申请人: LARCHE MARK
优先权: 2008
CN
US
5 件公开
Vaccine peptide combinations against cat allergy
US 8551492 B2
申请人: HAFNER RODERICK PETER
优先权: 2007
CN
US
4 件公开
Peptides for vaccine against birch allergy
US 9017689 B2
申请人: HAFNER RODERICK PETER
优先权: 2010
EP
US
4 件公开
SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES
EP 4294431 A4
申请人: BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC
优先权: 2021
EP
US
WO
3 件公开
Composition comprising a nucleotide sequence encoding an ELA2 fusion protein and plasmacytoid dendritic cells
US 10799553 B2
申请人: HUANG MALLEN
优先权: 2003
CN
US
3 件公开
Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and DDS using the same
US 8268321 B2
申请人: KIDO HIROSHI
优先权: 2004
CN
US
3 件公开
Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
US 8211442 B2
申请人: KIDO HIROSHI
优先权: 2005
CN
US
3 件公开
Pharmaceutical product for up-dosing of allergy vaccine
US 8491911 B2
申请人: JACOBI HENRIK HUGO
优先权: 2008
CN
US
3 件公开
第 1 / 8 页
上一页
下一页
药物
反馈